Novasenta Inc. — Form D
Novasenta Inc. of PITTSBURGH, PA, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-06. The offering totals $30.0M, of which $15.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-02-06
- Form: D
- Accession: 0001936994-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $30.0M
- Amount sold: $15.0M
- Remaining: $15.0M
- Investors: 1
- Date of first sale: 2023-12-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-504482
Issuer
- Name: Novasenta Inc.
- CIK: 0001936994
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 350 TECHNOLOGY DRIVE, PITTSBURGH, PA, 15219
- Phone: (412) 621-6200
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Jeanne Cunicelli | Director | Pittsburgh, PA |
| Greg Delgoffe | Director | Pittsburgh, PA |
| Matthias Kleinz | Director | Pittsburgh, PA |
| Mani Mohindru | Director | Pittsburgh, PA |
| David Moore | Director | Dallas, TX |
| Mani Mohindru | Executive Officer | Pittsburgh, PA |
Other filings by this issuer (1)
More